$11.51
0.10.88%
At close: -
$11.51
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
UroGen Pharma Earnings Estimates, EPS & Revenue | NASDAQ:URGN | Benzinga
UroGen Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 12
EPS Estimate
$-0.800
Quarterly Revenue Estimate
$22.69M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$90.40M
Analyze the earnings history of UroGen Pharma using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| URGN | UroGen Pharma | -$0.97 | -$0.80 | — | — | $18.78M | $22.69M | — | — | 05/12/2025 | Get Alert |
| URGN | UroGen Pharma | -$0.72 | -$0.72 | -$0.80 | -11.11% | $23.53M | $25.25M | $24.57M | -2.71% | 03/10/2025 | Get Alert |
| URGN | UroGen Pharma | -$0.68 | -$0.82 | -$0.55 | 32.93% | $20.85M | $24.20M | $25.20M | 4.15% | 11/06/2024 | Get Alert |
| URGN | UroGen Pharma | -$1.03 | -$0.84 | -$0.91 | -8.33% | $21.14M | $23.76M | $21.85M | -8.05% | 08/13/2024 | Get Alert |
| URGN | UroGen Pharma | -$1.30 | -$0.87 | -$0.97 | -11.49% | $17.19M | $21.38M | $18.78M | -12.16% | 05/13/2024 | Get Alert |
| URGN | UroGen Pharma | -$1.22 | -$0.68 | -$0.72 | -5.88% | $18.09M | $22.57M | $23.53M | 4.25% | 03/14/2024 | Get Alert |
| URGN | UroGen Pharma | -$1.13 | -$0.85 | -$0.68 | 20.00% | $16.10M | $20.03M | $20.85M | 4.10% | 11/14/2023 | Get Alert |
| URGN | UroGen Pharma | -$1.18 | -$1.14 | -$1.03 | 9.65% | $16.60M | $20.12M | $21.14M | 5.06% | 08/10/2023 | Get Alert |
| URGN | UroGen Pharma | -$1.25 | -$1.33 | -$1.30 | 2.26% | $13.56M | $17.18M | $17.19M | 0.07% | 05/11/2023 | Get Alert |
| URGN | UroGen Pharma | -$1.27 | -$1.07 | -$1.22 | -14.02% | $16.17M | $18.51M | $18.09M | -2.26% | 03/16/2023 | Get Alert |
| URGN | UroGen Pharma | -$1.35 | -$1.16 | -$1.13 | 2.59% | $11.35M | $20.15M | $16.10M | -20.11% | 11/10/2022 | Get Alert |
| URGN | UroGen Pharma | -$1.17 | -$1.23 | -$1.18 | 4.07% | $13.03M | $17.23M | $16.60M | -3.63% | 08/11/2022 | Get Alert |
| URGN | UroGen Pharma | -$1.17 | -$1.33 | -$1.25 | 6.02% | $7.49M | $15.18M | $13.56M | -10.65% | 05/10/2022 | Get Alert |
| URGN | UroGen Pharma | -$1.38 | -$1.17 | -$1.27 | -8.55% | $7.97M | $16.49M | $16.17M | -1.92% | 03/21/2022 | Get Alert |
| URGN | UroGen Pharma | -$1.31 | -$1.29 | -$1.35 | -4.65% | $3.46M | $15.42M | $11.35M | -26.39% | 11/15/2021 | Get Alert |
| URGN | UroGen Pharma | -$1.44 | -$1.27 | -$1.17 | 7.87% | $372.00K | $10.21M | $13.03M | 27.64% | 08/04/2021 | Get Alert |
| URGN | UroGen Pharma | -$1.79 | -$1.29 | -$1.17 | 9.30% | $0.00 | $9.05M | $7.49M | -17.29% | 05/13/2021 | Get Alert |
| URGN | UroGen Pharma | -$1.86 | -$1.37 | -$1.38 | -0.73% | $0.00 | $7.57M | $7.97M | 5.23% | 03/18/2021 | Get Alert |
| URGN | UroGen Pharma | -$1.06 | -$1.49 | -$1.31 | 12.08% | $0.00 | $3.34M | $3.46M | 3.62% | 11/09/2020 | Get Alert |
| URGN | UroGen Pharma | -$1.08 | -$1.58 | -$1.44 | 8.86% | $18.00K | $260.00K | $372.00K | 43.08% | 08/10/2020 | Get Alert |
| URGN | UroGen Pharma | -$1.11 | -$1.62 | -$1.79 | -10.49% | $0.00 | — | $0.00 | — | 05/07/2020 | Get Alert |
UroGen Pharma (URGN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-10 | $-0.80 | $-0.72 | -11.1 % |
| Q3 | 2024-11-06 | $-0.55 | $-0.82 | 32.9 % |
| Q2 | 2024-08-13 | $-0.91 | $-0.84 | -8.33 % |
| Q1 | 2024-05-13 | $-0.97 | $-0.87 | -11.5 % |
UroGen Pharma (URGN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-10 | $24.57M | $25.25M | -2.71 % |
| Q3 | 2024-11-06 | $25.20M | $24.20M | 4.15 % |
| Q2 | 2024-08-13 | $21.85M | $23.76M | -8.05 % |
| Q1 | 2024-05-13 | $18.78M | $21.38M | -12.2 % |
FAQ
When is UroGen Pharma (NASDAQ:URGN) reporting earnings?
UroGen Pharma (URGN) is scheduled to report earnings on May 12, 2025. The last reported earnings were for reported on March 10, 2025 for Q4.
What were the latest earnings per share (EPS) for UroGen Pharma (NASDAQ:URGN)?
The Actual EPS was $-0.80, which missed the estimate of $-0.72.
What were UroGen Pharma’s (NASDAQ:URGN) revenues?
The Actual Revenue was $24.6M, which missed the estimate of $25.3M.
Browse earnings estimates, EPS, and revenue on all stocks.
